For example, results of this study allow us to better understand a complex interaction of FVIII and LRP1 (Chun et al, under preparation), which can facilitate generation of longer-acting therapeutic FVIII for treatment of Hemophilia A. Future studies will investigate this mechanism in relation to other ligands of the LDLR family receptors. The gene discussed is F8; the disease is hemophilia A.